Aeon closes Seed extension alongside Aware Health acquisition
The extension takes total seed funding above €12m as Araya Ventures and existing backers support Aeon’s next phase.
Funding and acquisition context
Aeon closed the extension alongside its acquisition of Aware Health. The new round’s individual amount was undisclosed; the cumulative seed total builds on its €8.2m financing announced in June 2025. Araya Ventures co-led, with Concentric, GoHub Ventures, Kadmos Capital, Calm/Storm Ventures, N&V Capital and Bigwave Capital participating.
The acquired operation brings technology, laboratory integrations, equipment, customer relationships and a Berlin team. It had close to 10,000 active customers and more than 45 blood-draw locations. Aeon said customer data transfers require individual consent. The transaction adds recurring-testing infrastructure to its existing service as it expands in Germany.
Use of funds
Integrate Aware Health technology and team and accelerate European expansion.